Q8VIM5 (MYCD_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 100.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Myocardin Alternative name(s): Basic SAP coiled-coil transcription activator 2 SRF cofactor protein | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 935 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Smooth muscle cells (SM) and cardiac muscle cells-specific transcriptional factor which uses the canonical single or multiple CArG boxes DNA sequence. Acts as a cofactor of serum response factor (SRF) with the potential to modulate SRF-target genes. Plays a crucial role in cardiogenesis and differentiation of the smooth muscle cell lineage (myogenesis). Isoform 1 mediates the cardiac transcription factor MEF2C-dependent transcription. Isoform 1 and isoform 3 are more active than isoform 2 and isoform 4 in stimulating cardiac muscle promoters. Ref.1 Ref.5 Ref.8 Ref.11 Ref.13 |
| Subunit structure | Homodimer. Interacts with MLLT7/FOXO4 By similarity. Interacts with SRF, its association does not depend on specific DNA sequences for ternary complex formation. Interacts (via C-terminal) with EP300 (via CREB-binding domain). Interacts with HDAC4 and HDAC5. Interacts with MEF2C. Ref.1 Ref.8 Ref.10 Ref.11 |
| Subcellular location | Nucleus speckle. Note: Nuclear, with a punctate intranuclear pattern with exclusion from nuclei. Ref.1 Ref.10 |
| Tissue specificity | Expressed in heart, aorta, and in smooth muscle cell-containing tissues: stomach, bladder and uterus. Isoform 1 and isoform 3 are predominantly expressed in cardiac muscle whereas isoform 4 and isoform 5 are predominantly expressed in SMC-rich tissues. Isoform 3 is the most abundant isoform in the heart from embryo to adult. Ref.1 Ref.3 Ref.5 Ref.8 Ref.13 |
| Developmental stage | Detected in the cardiac crescent at 7.75 dpc and in the linear heart tube at 8.0 dpc and the developing atrial and aortic ventricular chambers until birth. Also detected in a subset of vascular and visceral smooth muscle cells: aortic arch arteries at 9.5 dpc; walls of the esophagus, dorsal aorta, pulmonary outflow tract, lung, gut, stomach, small intestine, bladder, and the head mesenchyme at 13.5 dpc until birth. Not detected in skeletal muscle cells. Ref.1 Ref.5 |
| Domain | The C-terminal region contains a general transcription activation domain. The N-terminal region, comprising a basic and a Gln-rich domain, confers transcriptional potency and specificity by mediating association with the MADS box of SRF. The basic domain may be required for nuclear localization. The SAP domain is important for transactivation and ternary complex formation. |
| Post-translational modification | Phosphorylation regulates negatively transcriptional activity. |
| Sequence similarities | Contains 3 RPEL repeats. Contains 1 SAP domain. |
Ontologies
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q8VIM5-1) Also known as: MYOCD-v2; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q8VIM5-2) Also known as: BSAC2A; Myocardin A; MYOCD-v5; The sequence of this isoform differs from the canonical sequence as follows: 1-128: Missing. 683-683: Q → QNSGAHEGHSSSFSSPASSLHQPFSGTQADSSHSAGLNPCPKSPSIHPK | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q8VIM5-3) Also known as: =Myocardin A; MYOCD-v1; The sequence of this isoform differs from the canonical sequence as follows: 683-683: Q → QNSGAHEGHSSSFSSPASSLHQPFSGTQADSSHSAGLNPCPKSPSIHPK | ||||||
| Isoform 4 (identifier: Q8VIM5-4) Also known as: MYOCD-v3; The sequence of this isoform differs from the canonical sequence as follows: 1-79: Missing. 683-683: Q → QNSGAHEGHSSSFSSPASSLHQPFSGTQADSSHSAGLNPCPKSPSIHPK | ||||||
| Isoform 5 (identifier: Q8VIM5-5) Also known as: MYOCD-v4; The sequence of this isoform differs from the canonical sequence as follows: 1-79: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 935 | 935 | Myocardin | PRO_0000126632 | |||||
Regions | |||||||||
| Repeat | 18 – 43 | 26 | RPEL 1 | ||||||
| Repeat | 62 – 87 | 26 | RPEL 2 | ||||||
| Repeat | 106 – 131 | 26 | RPEL 3 | ||||||
| Domain | 380 – 414 | 35 | SAP | ||||||
| Region | 153 – 201 | 49 | HDAC5-binding | ||||||
| Coiled coil | 287 – 322 | 36 | Potential | ||||||
| Coiled coil | 519 – 563 | 45 | Potential | ||||||
| Motif | 12 – 27 | 16 | MEF2C-binding | ||||||
| Compositional bias | 287 – 320 | 34 | Gln-rich | ||||||
| Compositional bias | 300 – 320 | 21 | Poly-Gln | ||||||
Amino acid modifications | |||||||||
| Modified residue | 454 | 1 | Phosphoserine; by GSK3-beta Ref.9 | ||||||
| Modified residue | 458 | 1 | Phosphoserine; by GSK3-beta Ref.9 | ||||||
| Modified residue | 462 | 1 | Phosphoserine; by GSK3-beta Ref.9 | ||||||
| Modified residue | 466 | 1 | Phosphoserine; by GSK3-beta | ||||||
| Modified residue | 624 | 1 | Phosphoserine; by GSK3-beta Ref.9 | ||||||
| Modified residue | 628 | 1 | Phosphoserine; by GSK3-beta Ref.9 | ||||||
| Modified residue | 632 | 1 | Phosphoserine; by GSK3-beta Ref.9 | ||||||
| Modified residue | 636 | 1 | Phosphoserine; by GSK3-beta Ref.9 | ||||||
| Modified residue | 812 | 1 | Phosphoserine; by MAPK1 AND MAPK3 Ref.12 | ||||||
| Modified residue | 859 | 1 | Phosphoserine; by MAPK1 and MAPK3 Ref.12 | ||||||
| Modified residue | 866 | 1 | Phosphoserine; by MAPK1 and MAPK3 Ref.12 | ||||||
| Modified residue | 893 | 1 | Phosphothreonine; by MAPK1 and MAPK3 Ref.12 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 128 | 128 | Missing in isoform 2. | VSP_007662 | |||||
| Alternative sequence | 1 – 79 | 79 | Missing in isoform 4 and isoform 5. | VSP_041684 | |||||
| Alternative sequence | 683 | 1 | Q → QNSGAHEGHSSSFSSPASSL HQPFSGTQADSSHSAGLNPC PKSPSIHPK in isoform 2, isoform 3 and isoform 4. | VSP_007663 | |||||
Experimental info | |||||||||
| Mutagenesis | 387 – 389 | 3 | ELR → PSF: Activation of ANF promoter abolished, no effect on SM22 promoter. Ref.1 | ||||||
| Mutagenesis | 408 – 410 | 3 | DRL → PGH: Activation of ANF promoter abolished, no effect on SM22 promoter. Ref.1 | ||||||
| Mutagenesis | 812 | 1 | S → A: No effect on SRF activation. No effect on SRF activation, on interaction with EP300 and on SM-promoter activation; when associated with A-859; A-866 and A-893. Ref.12 | ||||||
| Mutagenesis | 812 | 1 | S → D: No effect on SRF activation. Impairs SRF activation, reduces interaction with EP300 and SM-promoter activation; when associated with D-859; D-866 and D-893. Ref.12 | ||||||
| Mutagenesis | 859 | 1 | S → A: No effect on SRF activation; No effect on SRF activation. No effect on SRF activation, on interaction with EP300 and on SM-promoter activation; when associated with A-812, A-866 and A-893. Ref.12 | ||||||
| Mutagenesis | 859 | 1 | S → D: No effect on SRF activation. Impairs SRF activation, reduces interaction with EP300 and SM-promoter activation; when associated with D-812; D-866 and D-893. Ref.12 | ||||||
| Mutagenesis | 866 | 1 | S → A: No effect on SRF activation; No effect on SRF activation, on interaction with EP300 and on SM-promoter activation; when associated with A-812; A-859 and A-893. Ref.12 | ||||||
| Mutagenesis | 866 | 1 | S → D: No effect on SRF activation. Impairs SRF activation, reduces interaction with EP300 and SM-promoter activation; when associated with D-812; D-859 and D-893. Ref.12 | ||||||
| Mutagenesis | 893 | 1 | T → A: No effect on SRF activation; No effect on SRF activation, on interaction with EP300 and on SM-specific genes trancription; when associated with A-812; A-859 and A-866. Ref.12 | ||||||
| Mutagenesis | 893 | 1 | T → D: No effect on SRF activation. Impairs SRF activation, reduces interaction with EP300 and SM-promoter activation; when associated with D-812; D-859 and D-866. Ref.12 | ||||||
| Sequence conflict | 116 | 1 | P → Q in AAK71683. Ref.1 | ||||||
| Sequence conflict | 794 | 1 | D → G in AAK71683. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor." Wang D.-Z., Chang P.S., Wang Z., Sutherland L., Richardson J.A., Small E., Krieg P.A., Olson E.N. Cell 105:851-862(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, SUBCELLULAR LOCATION, INTERACTION WITH SRF, MUTAGENESIS OF 387-GLU--ARG-389 AND 408-ASP--LEU-410. Tissue: Heart. |
| [2] | "Potentiation of serum response factor activity by a family of myocardin-related transcription factors." Wang D.-Z., Li S., Hockemeyer D., Sutherland L., Wang Z., Schratt G., Richardson J.A., Nordheim A., Olson E.N. Proc. Natl. Acad. Sci. U.S.A. 99:14855-14860(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SEQUENCE REVISION TO 1-128. |
| [3] | "Myocardin expression is regulated by Nkx2.5, and its function is required for cardiomyogenesis." Ueyama T., Kasahara H., Ishiwata T., Nie Q., Izumo S. Mol. Cell. Biol. 23:9222-9232(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY. Strain: NIH Swiss. |
| [4] | "An alternative splicing form of myocardin (BSAC2), myocardin A (BSAC2A)." Sawada T., Okazaki T., Nakano H. Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). Strain: C57BL/6. Tissue: Heart. |
| [5] | "Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation." Du K.L., Ip H.S., Li J., Chen M., Dandre F., Yu W., Lu M.M., Owens G.K., Parmacek M.S. Mol. Cell. Biol. 23:2425-2437(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. |
| [6] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Strain: C57BL/6J. Tissue: Embryonic heart. |
| [7] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [8] | "Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes." Yoshida T., Sinha S., Dandre F., Wamhoff B.R., Hoofnagle M.H., Kremer B.E., Wang D.-Z., Olson E.N., Owens G.K. Circ. Res. 92:856-864(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY, INTERACTION WITH SRF. |
| [9] | "Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation." Badorff C., Seeger F.H., Zeiher A.M., Dimmeler S. Circ. Res. 97:645-654(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-454; SER-458; SER-462; SER-466: SER-624; SER-628; SER-632 AND SER-636. |
| [10] | "Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin." Cao D., Wang Z., Zhang C.L., Oh J., Xing W., Li S., Richardson J.A., Wang D.Z., Olson E.N. Mol. Cell. Biol. 25:364-376(2005) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, INTERACTION WITH EP300; HDAC4 AND HDAC5. |
| [11] | "Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR." Creemers E.E., Sutherland L.B., Oh J., Barbosa A.C., Olson E.N. Mol. Cell 23:83-96(2006) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE SPLICING (ISOFORMS 2 AND 4), INTERACTION WITH MEF2C, FUNCTION. |
| [12] | "Phosphorylation of myocardin by extracellular signal-regulated kinase." Taurin S., Sandbo N., Yau D.M., Sethakorn N., Kach J., Dulin N.O. J. Biol. Chem. 284:33789-33794(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-812; SER-859; SER-866 AND THR-893, MUTAGENESIS OF SER-812; SER-859; SER-866 AND THR-893. |
| [13] | "Expression and functional activity of four myocardin isoforms." Imamura M., Long X., Nanda V., Miano J.M. Gene 464:1-10(2010) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE SPLICING (ISOFORMS 1; 2; 3; 4 AND 5), TISSUE SPECIFICITY OF ISOFORMS, FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF384055 mRNA. Translation: AAK71683.2. AY303755 mRNA. Translation: AAQ63841.1. AF437877 mRNA. Translation: AAL30892.1. AK084700 mRNA. Translation: BAC39258.1. AK142216 mRNA. Translation: BAE24980.1. AL669846 Genomic DNA. Translation: CAI25017.1. |
| IPI | IPI00331360. IPI00876570. IPI00975097. IPI01027112. IPI01027190. |
| RefSeq | NP_660118.3. NM_145136.4. NP_666498.2. NM_146386.3. |
| UniGene | Mm.32257. |
3D structure databases | |
| ProteinModelPortal | Q8VIM5. |
| SMR | Q8VIM5. Positions 17-129, 372-422. |
| ModBase | Search... |
Protein-protein interaction databases | |
| DIP | DIP-29754N. |
PTM databases | |
| PhosphoSite | Q8VIM5. |
Proteomic databases | |
| PaxDb | Q8VIM5. |
| PRIDE | Q8VIM5. |
Protocols and materials databases | |
| DNASU | 214384. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000101042; ENSMUSP00000098603; ENSMUSG00000020542. ENSMUST00000102635; ENSMUSP00000099695; ENSMUSG00000020542. ENSMUST00000108695; ENSMUSP00000104335; ENSMUSG00000020542. |
| GeneID | 214384. |
| KEGG | mmu:214384. |
Organism-specific databases | |
| CTD | 93649. |
| MGI | MGI:2137495. Myocd. |
Phylogenomic databases | |
| eggNOG | NOG79803. |
| GeneTree | ENSGT00530000063195. |
| HOGENOM | HOG000038001. |
| HOVERGEN | HBG036493. |
| InParanoid | Q6W8X1. |
| OMA | SFTESPW. |
| OrthoDB | EOG4640BZ. |
Gene expression databases | |
| ArrayExpress | Q8VIM5. |
| Bgee | Q8VIM5. |
| CleanEx | MM_MYOCD. |
| Genevestigator | Q8VIM5. |
| GermOnline | ENSMUSG00000020542. Mus musculus. |
Family and domain databases | |
| Gene3D | 1.10.720.30. 1 hit. |
| InterPro | IPR004018. RPEL_repeat. IPR003034. SAP_dom. [Graphical view] |
| Pfam | PF02755. RPEL. 1 hit. PF02037. SAP. 1 hit. [Graphical view] |
| SMART | SM00707. RPEL. 3 hits. SM00513. SAP. 1 hit. [Graphical view] |
| PROSITE | PS51073. RPEL. 3 hits. PS50800. SAP. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 374288. |
| SOURCE | Search... |
Entry information
| Entry name | MYCD_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q8VIM5 Secondary accession number(s): Q5SS65 Q8VIL4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
